Sinil Pharmaceutical Co., Ltd. (KOSDAQ: 012790)
South Korea
· Delayed Price · Currency is KRW
6,400.00
-100.00 (-1.54%)
Dec 20, 2024, 9:00 AM KST
Sinil Pharmaceutical Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | 15,066 | 13,641 | 12,157 | 6,679 | 7,544 | 7,257 | Upgrade
|
Depreciation & Amortization | 5,361 | 5,361 | 4,432 | 4,536 | 4,432 | 4,282 | Upgrade
|
Loss (Gain) From Sale of Assets | 641.55 | 641.55 | -221.3 | -14 | -13.42 | 219.89 | Upgrade
|
Asset Writedown & Restructuring Costs | 7 | 7 | 92.08 | -14.5 | -97.5 | 14.57 | Upgrade
|
Loss (Gain) From Sale of Investments | 532.61 | 532.61 | 373.44 | -115.48 | 11.37 | 15.66 | Upgrade
|
Provision & Write-off of Bad Debts | 446.86 | 446.86 | 409.12 | 160.62 | 472.81 | 147.25 | Upgrade
|
Other Operating Activities | 3,089 | -408.83 | 2,903 | 2,102 | 565.25 | 2,606 | Upgrade
|
Change in Accounts Receivable | 1,095 | 1,095 | -3,247 | 161.49 | 147.62 | -2,485 | Upgrade
|
Change in Inventory | -2,304 | -2,304 | -3,487 | 236.85 | -1,865 | -1,679 | Upgrade
|
Change in Accounts Payable | -1,271 | -1,271 | 1,840 | 1,210 | -288.05 | 1,282 | Upgrade
|
Change in Other Net Operating Assets | 3,709 | -2,587 | -1,563 | -3,779 | 152.7 | 644.8 | Upgrade
|
Operating Cash Flow | 26,372 | 15,154 | 13,688 | 11,163 | 11,062 | 12,306 | Upgrade
|
Operating Cash Flow Growth | 132.16% | 10.72% | 22.62% | 0.92% | -10.11% | 33.84% | Upgrade
|
Capital Expenditures | -3,974 | -13,604 | -10,351 | -3,343 | -8,801 | -9,730 | Upgrade
|
Sale of Property, Plant & Equipment | -5,434 | 122.76 | 316.6 | 145.68 | 28.82 | 36.09 | Upgrade
|
Sale (Purchase) of Intangibles | -46.14 | -57 | -27.5 | -285.65 | -101.55 | -6.8 | Upgrade
|
Investment in Securities | -11,347 | 2,510 | -4,880 | -3,103 | 177.8 | -150.81 | Upgrade
|
Other Investing Activities | -338.56 | -291.6 | 62.27 | -95 | 29.95 | 37 | Upgrade
|
Investing Cash Flow | -21,139 | -11,319 | -14,880 | -6,665 | -8,609 | -9,868 | Upgrade
|
Short-Term Debt Issued | - | 22,578 | - | - | - | - | Upgrade
|
Total Debt Issued | 22,578 | 22,578 | - | - | - | - | Upgrade
|
Short-Term Debt Repaid | - | -22,578 | - | - | - | - | Upgrade
|
Long-Term Debt Repaid | - | -154.09 | -133.75 | -127.98 | -122.81 | -137.6 | Upgrade
|
Total Debt Repaid | -22,761 | -22,732 | -133.75 | -127.98 | -122.81 | -137.6 | Upgrade
|
Net Debt Issued (Repaid) | -183.53 | -154.09 | -133.75 | -127.98 | -122.81 | -137.6 | Upgrade
|
Repurchase of Common Stock | - | -73.39 | -104.49 | -168.43 | -6.26 | - | Upgrade
|
Dividends Paid | -1,965 | -1,112 | -1,081 | -1,051 | -1,126 | -1,051 | Upgrade
|
Other Financing Activities | 92 | 92 | - | -0 | - | - | Upgrade
|
Financing Cash Flow | -2,057 | -1,248 | -1,319 | -1,347 | -1,255 | -1,188 | Upgrade
|
Foreign Exchange Rate Adjustments | -12.23 | -11.37 | 114.94 | 25.44 | -9.82 | -1.53 | Upgrade
|
Miscellaneous Cash Flow Adjustments | -0 | -0 | - | - | - | - | Upgrade
|
Net Cash Flow | 3,164 | 2,576 | -2,396 | 3,176 | 1,188 | 1,248 | Upgrade
|
Free Cash Flow | 22,398 | 1,551 | 3,336 | 7,820 | 2,261 | 2,576 | Upgrade
|
Free Cash Flow Growth | - | -53.52% | -57.33% | 245.93% | -12.24% | 199.72% | Upgrade
|
Free Cash Flow Margin | 24.43% | 1.74% | 4.17% | 12.66% | 3.68% | 4.25% | Upgrade
|
Free Cash Flow Per Share | 1937.87 | 134.13 | 288.44 | 702.52 | 201.11 | 228.96 | Upgrade
|
Cash Interest Paid | 22.19 | 26.13 | 6.05 | 9.72 | 13.24 | 0.23 | Upgrade
|
Cash Income Tax Paid | 846.99 | 3,081 | 772.84 | 1,113 | 1,721 | -3.52 | Upgrade
|
Levered Free Cash Flow | 17,960 | -2,857 | 148.73 | 8,141 | -2,130 | 102.11 | Upgrade
|
Unlevered Free Cash Flow | 17,974 | -2,840 | 152.52 | 8,147 | -2,122 | 237.62 | Upgrade
|
Change in Net Working Capital | -7,205 | 3,286 | 2,436 | -2,251 | 1,790 | 191.44 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.